Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database
Pierre‐Marie Morice, Alexandra Léary, Charles Dolladille, Basile Chrétien, Laurent Poulain, Antonio González-Martı́n, Kathleen N. Moore, Eileen M. O’Reilly, Isabelle Ray‐Coquard, Joachim Alexandre
Topics & Concepts
MedicinePharmacovigilanceMyeloid leukaemiaMyelodysplastic syndromesMeta-analysisInternal medicineOncologyDatabaseAdverse effectBone marrowComputer sciencePARP inhibition in cancer therapyAdvanced Breast Cancer TherapiesOvarian cancer diagnosis and treatment